首页> 美国卫生研究院文献>Frontiers in Oncology >Evaluation of Apoptosis and Autophagy Inducing Potential of Berberis aristata Azadirachta indica and Their Synergistic Combinations in Parental and Resistant Human Osteosarcoma Cells
【2h】

Evaluation of Apoptosis and Autophagy Inducing Potential of Berberis aristata Azadirachta indica and Their Synergistic Combinations in Parental and Resistant Human Osteosarcoma Cells

机译:小Ber印za及其亲本和耐药人骨肉瘤细胞的凋亡和自噬诱导潜力及其协同组合的评价。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cancer is a multifactorial disease and hence can be effectively overcome by a multi-constituently therapeutic strategy. Medicinal plant extracts represent a perfect example of such stratagem. However, minimal studies have been done till date that portray the effect of extraction techniques on the phyto-constituent profile of plant extracts and its impact on anticancer activity. In the present study, we have evaluated the anticancer potential of methanolic extracts of Berberis aristata root and Azadirachta indica seeds prepared by various extraction techniques in human osteosarcoma (HOS) cells. Soxhlation extract of B. aristata (BAM-SX) and sonication extract of A. indica (AIM-SO) were most effective in inducing apoptosis in parental drug sensitive, as well as resistant cell type developed by repeated drug exposure. Generation of reactive oxygen species and cell cycle arrest preceded caspase-mediated apoptosis in HOS cells. Interestingly, inhibition of autophagy enhanced cell death suggesting the cytoprotective role of autophagy. Combination studies of different methanolic extracts of BAM and AIM were performed, among which, the combination of BAM-SO and AIM-SO (BAAISO) was found to show synergism (IC50 10.27 µg/ml) followed by combination of BAM-MC and AIM-MC (BAAIMC) with respect to other combinations in the ratio of 1:1. BAAISO also showed synergism when it was added to cisplatin-resistant HOS cells (HCR). Chromatographic profiling of BAM-SX and AIM-SO by high performance thin layer chromatography resulted in identification of berberine (Rf 0.55), palmitine (Rf 0.50) in BAM-SX and azadirachtin A (Rf 0.36), azadirachtin B (Rf 0.56), nimbin (Rf 0.80), and nimbolide (Rf 0.43) in AIM-SO. The cytotoxic sensitivity obtained can be attributed to the above compounds. Our results highlight the importance of extraction technique and subsequent mechanism of action of multi-constituential B. aristata and A. indica against both sensitive and drug refractory HOS cells.
机译:癌症是一种多因素疾病,因此可以通过多成分治疗策略有效地克服。药用植物提取物代表了这种战略的完美例子。然而,迄今为止,已经进行了最少的研究,这些研究描述了提取技术对植物提取物的植物组成特征及其对抗癌活性的影响。在本研究中,我们评估了通过各种提取技术制备的小Ber小Ber根和印za种子的甲醇提取物在人骨肉瘤(HOS)细胞中的抗癌潜力。棉铃虫的浸提提取物(BAM-SX)和印度。草的超声提取物(AIM-SO)在诱导亲代药物敏感的细胞凋亡以及通过反复接触药物产生的耐药细胞类型方面最有效。活性氧的产生和细胞周期停滞先于caspase介导的HOS细胞凋亡。有趣的是,自噬的抑制增强了细胞死亡,提示自噬的细胞保护作用。对BAM和AIM的不同甲醇提取物进行了组合研究,其中BAM-SO和AIM-SO(BAAISO)的组合显示出协同作用(IC5010.27μg/ ml),然后BAM-MC和AIM组合-MC(BAAIMC)对于其他组合的比例为1:1。将BAAISO加入耐顺铂的HOS细胞(HCR)后,也显示出协同作用。通过高效薄层色谱对BAM-SX和AIM-SO进行色谱分析,可鉴定BAM-SX中的小ber碱(Rf 0.55),棕榈酸(Rf 0.50)和印za素A(Rf 0.36),印za素B(Rf 0.56), Nimbin(Rf 0.80)和Nimbolide(Rf 0.43)在AIM-SO中。获得的细胞毒性敏感性可以归因于上述化合物。我们的结果突出了提取技术的重要性以及多成分B. aristata和A. indica对敏感和难治性HOS细胞的作用机理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号